Marco Soster

780 total citations
15 papers, 597 citations indexed

About

Marco Soster is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Marco Soster has authored 15 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Biomedical Engineering and 4 papers in Biomaterials. Recurrent topics in Marco Soster's work include Nanoparticle-Based Drug Delivery (4 papers), Nanoplatforms for cancer theranostics (3 papers) and Cancer Mechanisms and Therapy (2 papers). Marco Soster is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Nanoplatforms for cancer theranostics (3 papers) and Cancer Mechanisms and Therapy (2 papers). Marco Soster collaborates with scholars based in Italy, Belarus and United States. Marco Soster's co-authors include Roberta Cavalli, Monica Argenziano, Serena Marchiò, Federico Bussolino, Massimo Aglietta, Loretta Gammaitoni, Gloria Uccello‐Barretta, Valentina Brunella, Miriam Biasizzo and Chiara Riedo and has published in prestigious journals such as Clinical Cancer Research, FEBS Letters and Journal of Controlled Release.

In The Last Decade

Marco Soster

15 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Soster Italy 11 201 195 121 82 81 15 597
David Kryza France 15 194 1.0× 216 1.1× 177 1.5× 143 1.7× 222 2.7× 55 782
Laurence Van Gulick France 14 160 0.8× 152 0.8× 118 1.0× 82 1.0× 51 0.6× 24 499
Thomas Nielsen Denmark 17 197 1.0× 300 1.5× 297 2.5× 127 1.5× 77 1.0× 45 895
Desirée Wünsch Germany 14 279 1.4× 135 0.7× 157 1.3× 117 1.4× 44 0.5× 24 587
Isaac M. Adjei United States 15 253 1.3× 328 1.7× 188 1.6× 161 2.0× 61 0.8× 22 848
Ella N. Hoogenboezem United States 6 265 1.3× 159 0.8× 186 1.5× 67 0.8× 53 0.7× 9 563
Tanner K. Hill United States 10 146 0.7× 261 1.3× 186 1.5× 73 0.9× 83 1.0× 11 516
Zhihua Wu China 15 374 1.9× 395 2.0× 173 1.4× 140 1.7× 87 1.1× 42 862
Asiri Ediriwickrema United States 12 238 1.2× 142 0.7× 119 1.0× 51 0.6× 63 0.8× 22 628

Countries citing papers authored by Marco Soster

Since Specialization
Citations

This map shows the geographic impact of Marco Soster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Soster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Soster more than expected).

Fields of papers citing papers by Marco Soster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Soster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Soster. The network helps show where Marco Soster may publish in the future.

Co-authorship network of co-authors of Marco Soster

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Soster. A scholar is included among the top collaborators of Marco Soster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Soster. Marco Soster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Baroni, Simona, Monica Argenziano, Marco Soster, et al.. (2023). Hard-Shelled Glycol Chitosan Nanoparticles for Dual MRI/US Detection of Drug Delivery/Release: A Proof-of-Concept Study. Nanomaterials. 13(15). 2227–2227. 6 indexed citations
2.
Argenziano, Monica, Sergio Occhipinti, Anna Scomparin, et al.. (2022). Exploring chitosan-shelled nanobubbles to improve HER2 + immunotherapy via dendritic cell targeting. Drug Delivery and Translational Research. 12(8). 2007–2018. 24 indexed citations
3.
Cavalli, Roberta, Marco Soster, & Monica Argenziano. (2016). Nanobubbles: A Promising Efficient Tool for Therapeutic Delivery. Therapeutic Delivery. 7(2). 117–138. 135 indexed citations
4.
Trotta, Francesco, Fabrizio Caldera, Roberta Cavalli, et al.. (2016). Molecularly imprinted cyclodextrin nanosponges for the controlled delivery of L-DOPA: perspectives for the treatment of Parkinson’s disease. Expert Opinion on Drug Delivery. 13(12). 1671–1680. 71 indexed citations
5.
Basilico, Nicoletta, Sarah D’Alessandro, Alice Panariti, et al.. (2015). Dextran-shelled oxygen-loaded nanodroplets reestablish a normoxia-like pro-angiogenic phenotype and behavior in hypoxic human dermal microvascular endothelium. Toxicology and Applied Pharmacology. 288(3). 330–338. 30 indexed citations
6.
Pignochino, Ymera, Carmine Dell’Aglio, Simona Inghilleri, et al.. (2015). The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma. BMC Cancer. 15(1). 374–374. 26 indexed citations
7.
Gulino, Giulia Rossana, Amina Khadjavi, Alice Panariti, et al.. (2015). Oxygen‐Loaded Nanodroplets Effectively Abrogate Hypoxia Dysregulating Effects on Secretion of MMP‐9 and TIMP‐1 by Human Monocytes. Mediators of Inflammation. 2015(1). 964838–964838. 17 indexed citations
8.
Soster, Marco, Amina Khadjavi, R. Ciprian, et al.. (2015). PO-1068: Characterization of superparamagnetic, oxygen loaded NanoBubbles for hyperthermia and radiotherapy. Radiotherapy and Oncology. 115. S576–S576. 3 indexed citations
9.
Peraldo‐Neia, Caterina, Giuliana Cavalloni, Marco Soster, et al.. (2014). Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models. BMC Cancer. 14(1). 918–918. 7 indexed citations
10.
Pignochino, Ymera, Carmine Dell’Aglio, Marco Basiricò, et al.. (2013). The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models. Clinical Cancer Research. 19(8). 2117–2131. 91 indexed citations
11.
Soster, Marco, et al.. (2013). The V1/V2 loop of HIV‐1 gp120 is necessary for Tat binding and consequent modulation of virus entry. FEBS Letters. 587(18). 2943–2951. 8 indexed citations
12.
Cavalloni, Giuliana, Caterina Peraldo‐Neia, Ivana Sarotto, et al.. (2012). Antitumor Activity of Src Inhibitor Saracatinib (AZD-0530) in Preclinical Models of Biliary Tract Carcinomas. Molecular Cancer Therapeutics. 11(7). 1528–1538. 13 indexed citations
13.
Marchiò, Serena, Marco Soster, Andrea Muratore, et al.. (2012). A complex of α 6 integrin and E‐cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin‐like 6. EMBO Molecular Medicine. 4(11). 1156–1175. 39 indexed citations
14.
Virga, Alessandro, Paola Rivolo, Emiliano Descrovi, et al.. (2011). SERS active Ag nanoparticles in mesoporous silicon: detection of organic molecules and peptide–antibody assays. Journal of Raman Spectroscopy. 43(6). 730–736. 67 indexed citations
15.
Loi, Monica, Serena Marchiò, Pamela Becherini, et al.. (2010). Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma. Journal of Controlled Release. 145(1). 66–73. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026